Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the March kets Covered in the Report
3.1 In Vitro Diagnostics
3.2 Clinical Chemistry
3.3 Genetic Testing
3.4 Haematology
3.5 Histology And Cytology
3.6 Immuno Chemistry
3.7 Infectious Immunology
3.8 Microbiology Culture
4 Global In Vitro Diagnostics
4.1 In Vitro Diagnostics, Global, Overall Revenue ($ mn), from 2000 to 2015
4.2 In Vitro Diagnostics, Global, Firms Share (2007-2008)
5 In Vitro Diagnostics In United States
5.1 In Vitro Diagnostics, United States, Overall Revenue ($ mn), from 2000 to 2015
5.2 In Vitro Diagnostics, United States, Distribution Share (2007-2008)
5.3 In Vitro Diagnostics, United States, Firms Share (2007-2008)
6 In Vitro Diagnostics In Japan
6.1 In Vitro Diagnostics, Japan, Overall Revenue ($ mn), from 2000 to 2015
6.2 In Vitro Diagnostics, Japan, Distribution Share (2007-2008)
6.3 In Vitro Diagnostics, Japan, Firms Share (2007-2008)
7 In Vitro Diagnostics In Germany
7.1 In Vitro Diagnostics, Germany, Overall Revenue ($ mn), from 2000 to 2015
7.2 In Vitro Diagnostics, Germany, Distribution Share (2007-2008)
7.3 In Vitro Diagnostics, Germany, Firms Share (2007-2008)
8 In Vitro Diagnostics In Italy
8.1 In Vitro Diagnostics, Italy, Overall Revenue ($ mn), from 2000 to 2015
8.2 In Vitro Diagnostics, Italy, Distribution Share (2007-2008)
8.3 In Vitro Diagnostics, Italy, Firms Share (2007-2008)
9 In Vitro Diagnostics In France
9.1 In Vitro Diagnostics, France, Overall Revenue ($ mn), from 2000 to 2015
9.2 In Vitro Diagnostics, France, Distribution Share (2007-2008)
9.3 In Vitro Diagnostics, France, Firms Share (2007-2008)
10 In Vitro Diagnostics In China
10.1 In Vitro Diagnostics, China, Overall Revenue ($ mn), from 2000 to 2015
10.2 In Vitro Diagnostics, China, Distribution Share (2007-2008)
10.3 In Vitro Diagnostics, China, Firms Share (2007-2008)
11 In Vitro Diagnostics In Spain
11.1 In Vitro Diagnostics, Spain, Overall Revenue ($ mn), from 2000 to 2015
11.2 In Vitro Diagnostics, Spain, Distribution Share (2007-2008)
11.3 In Vitro Diagnostics, Spain, Firms Share (2007-2008)
12 In Vitro Diagnostics In United Kingdom
12.1 In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), from 2000 to 2015
12.2 In Vitro Diagnostics, United Kingdom, Distribution Share (2007-2008)
12.3 In Vitro Diagnostics, United Kingdom, Firms Share (2007-2008)
13 In Vitro Diagnostics In Brazil
13.1 In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), from 2000 to 2015
13.2 In Vitro Diagnostics, Brazil, Distribution Share (2007-2008)
13.3 In Vitro Diagnostics, Brazil, Firms Share (2007-2008)
14 In Vitro Diagnostics In Canada
14.1 In Vitro Diagnostics, Canada, Overall Revenue ($ mn), from 2000 to 2015
14.2 In Vitro Diagnostics, Canada, Distribution Share (2007-2008)
14.3 In Vitro Diagnostics, Canada, Firms Share (2007-2008)
15 In Vitro Diagnostics In India
15.1 In Vitro Diagnostics, India, Overall Revenue ($ mn), from 2000 to 2015
15.2 In Vitro Diagnostics, India, Distribution Share (2007-2008)
15.3 In Vitro Diagnostics, India, Firms Share (2007-2008)
16 In Vitro Diagnostics In Australia
16.1 In Vitro Diagnostics, Australia, Overall Revenue ($ mn), from 2000 to 2015
16.2 In Vitro Diagnostics, Australia, Distribution Share (2007-2008)
16.3 In Vitro Diagnostics, Australia, Firms Share (2007-2008)
17 Overview of Key Firms in Global In Vitro Diagnostics March ket
17.1 F. Hoffmann-La Roche Ltd.
17.2 Siemens Healthcare
17.3 Sysmex Corporation
17.4 Abbott Laboratories
17.5 Beckman Coulter, Inc.
17.6 Ortho-Clinical Diagnostics Inc.
17.7 OLYMPUS CORPORATION
17.8 Qiagen N.V.
17.9 bioMerieux S.A.
17.10 Bio-Rad Laboratories, Inc.
17.11 Phadia AB
17.12 DiaSorin S.p.A
17.13 Becton, Dickinson and Firms
17.14 Gen-Probe Incorporated
17.15 Inverness Medical Innovations, Inc.
17.16 Ventana Medical Systems, Inc.
17.17 Hologic, Inc.
17.18 Dade Behring Holdings, Inc.
17.19 Calypte Biomedical Corporation
17.20 CytoCore, Inc.
17.21 Daxor Corporation
17.22 IRIS International, Inc.
17.23 Onconome, Inc.
17.24 Streck, Inc.
17.25 Targeted Diagnostics & Therapeutics, Inc.
17.26 Biovest International, Inc.
17.27 Biomeda Corp.
17.28 Quidel Corporation
17.29 American Bio Medica Corporation
17.30 AMPCOR Technologies, Inc.
17.31 Laboratory Corporation of America Holdings
17.32 American Diagnostica Inc.
17.33 GRANT Life Sciences, Inc.
17.34 Luminex Corporation
17.35 Akonni Biosystems Inc
17.36 Progentech USA, Inc.
17.37 Source MDx
17.38 GeneWorks Pty. Ltd.
17.39 Astral Scientific Pty Ltd
17.40 Eiken Chemical Co.,Ltd.
17.41 Cosmo Bio Co., Ltd.
17.42 Techno Medica Co., Ltd.
17.43 China Medical Technologies, Inc.
17.44 Beijing Pason Pharmaceuticals Inc.
17.45 Jingmei Biotech Co.,Ltd.
17.46 Beijing Bio-Ekon Biotechnology Co., Ltd.
17.47 China Sky One Medical, Inc.
18 Financial Deals Landscape
18.1 Merger
18.2 Acquisition
18.3 Partnerships
19 Recent Developments
19.1 Strategy And Business Planning
19.2 Legal and Regulatory
19.3 Government and Public Interest
19.4 Other Significant Developments
20 Appendix
20.1 Global March kets Direct Research Methodology
20.2 Secondary Research
20.3 Primary Research
20.4 Models
20.5 Projections
20.6 Expert Panel Validation
20.7 Currency Conversion
20.8 Contact Us
20.9 Disclaimer
List of Tables
1.1 List of Tables
Table 1: In Vitro Diagnostics, Global, Overall Revenue ($ mn), from 2000 to 2015 37
Table 2: Global In Vitro Diagnostics March ket, Cross- Category Analysis, from 2000 to 2015 38
Table 3: In Vitro Diagnostics, Global, Overall Revenue ($ mn), Historic, from 2000 to 2008 40
Table 4: In Vitro Diagnostics, Global, Overall Revenue ($ mn), Projection , from 2008 to 2015 42
Table 5: In Vitro Diagnostics, Global, Firms Share by Revenue ($ mn), from 2007 to 2008 43
Table 6: In Vitro Diagnostics, United States, Overall Revenue ($ mn), from 2000 to 2015 44
Table 7: In Vitro Diagnostics, United States, Overall Revenue ($ mn), Historic, from 2000 to 2008 46
Table 8: In Vitro Diagnostics, United States, Overall Revenue ($ mn), Projection , from 2008 to 2015 48
Table 9: Clinical Chemistry, United States, Distribution Share by Revenue ($mn), from 2007 to 2008 49
Table 10: Genetic Testing, United States, Distribution Share by Revenue ($mn), from 2007 to 2008 49
Table 11: Haematology, United States, Distribution Share by Revenue ($mn), from 2007 to 2008 50
Table 12: Histology And Cytology, United States, Distribution Share by Revenue ($mn), from 2007 to 2008 50
Table 13: Immuno Chemistry, United States, Distribution Share by Revenue ($mn), from 2007 to 2008 51
Table 14: Infectious Immunology, United States, Distribution Share by Revenue ($mn), from 2007 to 2008 51
Table 15: Microbiology Culture, United States, Distribution Share by Revenue ($mn), from 2007 to 2008 52
Table 16: In Vitro Diagnostics, United States, Firms Share by Revenue ($ mn), from 2007 to 2008 53
Table 17: Clinical Chemistry, United States, Firms Share by Revenue ($ mn), from 2007 to 2008 54
Table 18: Genetic Testing, United States, Firms Share by Revenue ($ mn), from 2007 to 2008 55
Table 19: Haematology, United States, Firms Share by Revenue ($ mn), from 2007 to 2008 56
Table 20: Histology And Cytology, United States, Firms Share by Revenue ($ mn), from 2007 to 2008 57
Table 21: Immuno Chemistry, United States, Firms Share by Revenue ($ mn), from 2007 to 2008 59
Table 22: Infectious Immunology, United States, Firms Share by Revenue ($ mn), from 2007 to 2008 61
Table 23: Microbiology Culture, United States, Firms Share by Revenue ($ mn), from 2007 to 2008 62
Table 24: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), from 2000 to 2015 63
Table 25: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Historic, from 2000 to 2008 65
Table 26: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Projection , from 2008 to 2015 67
Table 27: Clinical Chemistry, Japan, Distribution Share by Revenue ($mn), from 2007 to 2008 68
Table 28: Genetic Testing, Japan, Distribution Share by Revenue ($mn), from 2007 to 2008 68
Table 29: Haematology, Japan, Distribution Share by Revenue ($mn), from 2007 to 2008 69
Table 30: Histology And Cytology, Japan, Distribution Share by Revenue ($mn), from 2007 to 2008 69
Table 31: Immuno Chemistry, Japan, Distribution Share by Revenue ($mn), from 2007 to 2008 70
Table 32: Infectious Immunology, Japan, Distribution Share by Revenue ($mn), from 2007 to 2008 70
Table 33: Microbiology Culture, Japan, Distribution Share by Revenue ($mn), from 2007 to 2008 71
Table 34: In Vitro Diagnostics, Japan, Firms Share by Revenue ($ mn), from 2007 to 2008 72
Table 35: Clinical Chemistry, Japan, Firms Share by Revenue ($ mn), from 2007 to 2008 73
Table 36: Genetic Testing, Japan, Firms Share by Revenue ($ mn), from 2007 to 2008 74
Table 37: Haematology, Japan, Firms Share by Revenue ($ mn), from 2007 to 2008 75
Table 38: Histology And Cytology, Japan, Firms Share by Revenue ($ mn), from 2007 to 2008 76
Table 39: Immuno Chemistry, Japan, Firms Share by Revenue ($ mn), from 2007 to 2008 78
Table 40: Infectious Immunology, Japan, Firms Share by Revenue ($ mn), from 2007 to 2008 80
Table 41: Microbiology Culture, Japan, Firms Share by Revenue ($ mn), from 2007 to 2008 81
Table 42: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), from 2000 to 2015 82
Table 43: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Historic, from 2000 to 2008 84
Table 44: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Projection , from 2008 to 2015 86
Table 45: Clinical Chemistry, Germany, Distribution Share by Revenue ($mn), from 2007 to 2008 87
Table 46: Genetic Testing, Germany, Distribution Share by Revenue ($mn), from 2007 to 2008 87
Table 47: Haematology, Germany, Distribution Share by Revenue ($mn), from 2007 to 2008 88
Table 48: Histology and Cytology, Germany, Distribution Share by Revenue ($mn), from 2007 to 2008 88
Table 49: Immuno Chemistry, Germany, Distribution Share by Revenue ($mn), from 2007 to 2008 89
Table 50: Infectious Immunology, Germany, Distribution Share by Revenue ($mn), from 2007 to 2008 89
Table 51: Microbiology Culture, Germany, Distribution Share by Revenue ($mn), from 2007 to 2008 90
Table 52: In Vitro Diagnostics, Germany, Firms Share by Revenue ($ mn), from 2007 to 2008 91
Table 53: Clinical Chemistry, Germany, Firms Share by Revenue ($ mn), from 2007 to 2008 92
Table 54: Genetic Testing, Germany, Firms Share by Revenue ($ mn), from 2007 to 2008 93
Table 55: Haematology, Germany, Firms Share by Revenue ($ mn), from 2007 to 2008 95
Table 56: Histology And Cytology, Germany, Firms Share by Revenue ($ mn), from 2007 to 2008 96
Table 57: Immuno Chemistry, Germany, Firms Share by Revenue ($ mn), from 2007 to 2008 98
Table 58: Infectious Immunology, Germany, Firms Share by Revenue ($ mn), from 2007 to 2008 100
Table 59: Microbiology Culture, Germany, Firms Share by Revenue ($ mn), from 2007 to 2008 101
Table 60: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), from 2000 to 2015 102
Table 61: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Historic, from 2000 to 2008 104
Table 62: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Projection , from 2008 to 2015 106
Table 63: Clinical Chemistry, Italy, Distribution Share by Revenue ($mn), from 2007 to 2008 107
Table 64: Genetic Testing, Italy, Distribution Share by Revenue ($mn), from 2007 to 2008 107
Table 65: Haematology, Italy, Distribution Share by Revenue ($mn), from 2007 to 2008 108
Table 66: Histology And Cytology, Italy, Distribution Share by Revenue ($mn), from 2007 to 2008 108
Table 67: Immuno Chemistry, Italy, Distribution Share by Revenue ($mn), from 2007 to 2008 109
Table 68: Infectious Immunology, Italy, Distribution Share by Revenue ($mn), from 2007 to 2008 109
Table 69: Microbiology Culture, Italy, Distribution Share by Revenue ($mn), from 2007 to 2008 110
Table 70: In Vitro Diagnostics, Italy, Firms Share by Revenue ($ mn), from 2007 to 2008 111
Table 71: Clinical Chemistry, Italy, Firms Share by Revenue ($ mn), from 2007 to 2008 112
Table 72: Genetic Testing, Italy, Firms Share by Revenue ($ mn), from 2007 to 2008 113
Table 73: Haematology, Italy, Firms Share by Revenue ($ mn), from 2007 to 2008 114
Table 74: Histology And Cytology, Italy, Firms Share by Revenue ($ mn), from 2007 to 2008 116
Table 75: Immuno Chemistry, Italy, Firms Share by Revenue ($ mn), from 2007 to 2008 118
Table 76: Infectious Immunology, Italy, Firms Share by Revenue ($ mn), from 2007 to 2008 120
Table 77: Microbiology Culture, Italy, Firms Share by Revenue ($ mn), from 2007 to 2008 121
Table 78: In Vitro Diagnostics, France, Overall Revenue ($ mn), from 2000 to 2015 122
Table 79: In Vitro Diagnostics, France, Overall Revenue ($ mn), Historic, from 2000 to 2008 124
Table 80: In Vitro Diagnostics, France, Overall Revenue ($ mn), Projection , from 2008 to 2015 126
Table 81: Clinical Chemistry, France, Distribution Share by Revenue ($mn), from 2007 to 2008 127
Table 82: Genetic Testing, France, Distribution Share by Revenue ($mn), from 2007 to 2008 127
Table 83: Haematology, France, Distribution Share by Revenue ($mn), from 2007 to 2008 128
Table 84: Histology And Cytology, France, Distribution Share by Revenue ($mn), from 2007 to 2008 128
Table 85: Immuno Chemistry, France, Distribution Share by Revenue ($mn), from 2007 to 2008 129
Table 86: Infectious Immunology, France, Distribution Share by Revenue ($mn), from 2007 to 2008 129
Table 87: Microbiology Culture, France, Distribution Share by Revenue ($mn), from 2007 to 2008 130
Table 88: In Vitro Diagnostics, France, Firms Share by Revenue ($ mn), from 2007 to 2008 131
Table 89: Clinical Chemistry, France, Firms Share by Revenue ($ mn), from 2007 to 2008 132
Table 90: Genetic Testing, France, Firms Share by Revenue ($ mn), from 2007 to 2008 133
Table 91: Haematology, France, Firms Share by Revenue ($ mn), from 2007 to 2008 134
Table 92: Histology And Cytology, France, Firms Share by Revenue ($ mn), from 2007 to 2008 135
Table 93: Immuno Chemistry, France, Firms Share by Revenue ($ mn), from 2007 to 2008 137
Table 94: Infectious Immunology, France, Firms Share by Revenue ($ mn), from 2007 to 2008 139
Table 95: Microbiology Culture, France, Firms Share by Revenue ($ mn), from 2007 to 2008 140
Table 96: In Vitro Diagnostics, China, Overall Revenue ($ mn), from 2000 to 2015 141
Table 97: In Vitro Diagnostics, China, Overall Revenue ($ mn), Historic, from 2000 to 2008 143
Table 98: In Vitro Diagnostics, China, Overall Revenue ($ mn), Projection , from 2008 to 2015 145
Table 99: Clinical Chemistry, China, Distribution Share by Revenue ($mn), from 2007 to 2008 146
Table 100: Genetic Testing, China, Distribution Share by Revenue ($mn), from 2007 to 2008 146
Table 101: Haematology, China, Distribution Share by Revenue ($mn), from 2007 to 2008 147
Table 102: Histology And Cytology, China, Distribution Share by Revenue ($mn), from 2007 to 2008 147
Table 103: Immuno Chemistry, China, Distribution Share by Revenue ($mn), from 2007 to 2008 148
Table 104: Infectious Immunology, China, Distribution Share by Revenue ($mn), from 2007 to 2008 148
Table 105: Microbiology Culture, China, Distribution Share by Revenue ($mn), from 2007 to 2008 149
Table 106: In Vitro Diagnostics, China, Firms Share by Revenue ($ mn), from 2007 to 2008 150
Table 107: Clinical Chemistry, China, Firms Share by Revenue ($ mn), from 2007 to 2008 152
Table 108: Genetic Testing, China, Firms Share by Revenue ($ mn), from 2007 to 2008 153
Table 109: Haematology, China, Firms Share by Revenue ($ mn), from 2007 to 2008 154
Table 110: Histology And Cytology, China, Firms Share by Revenue ($ mn), from 2007 to 2008 155
Table 111: Immuno Chemistry, China, Firms Share by Revenue ($ mn), from 2007 to 2008 157
Table 112: Infectious Immunology, China, Firms Share by Revenue ($ mn), from 2007 to 2008 159
Table 113: Microbiology Culture, China, Firms Share by Revenue ($ mn), from 2007 to 2008 160
Table 114: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), from 2000 to 2015 161
Table 115: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Historic, from 2000 to 2008 163
Table 116: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Projection , from 2008 to 2015 165
Table 117: Clinical Chemistry, Spain, Distribution Share by Revenue ($mn), from 2007 to 2008 166
Table 118: Genetic Testing, Spain, Distribution Share by Revenue ($mn), from 2007 to 2008 166
Table 119: Haematology, Spain, Distribution Share by Revenue ($mn), from 2007 to 2008 167
Table 120: Histology and Cytology, Spain, Distribution Share by Revenue ($mn), from 2007 to 2008 167
Table 121: Immuno Chemistry, Spain, Distribution Share by Revenue ($mn), from 2007 to 2008 168
Table 122: Infectious Immunology, Spain, Distribution Share by Revenue ($mn), from 2007 to 2008 168
Table 123: Microbiology Culture, Spain, Distribution Share by Revenue ($mn), from 2007 to 2008 169
Table 124: In Vitro Diagnostics, Spain, Firms Share by Revenue ($ mn), from 2007 to 2008 170
Table 125: Clinical Chemistry, Spain, Firms Share by Revenue ($ mn), from 2007 to 2008 171
Table 126: Genetic Testing, Spain, Firms Share by Revenue ($ mn), from 2007 to 2008 172
Table 127: Haematology, Spain, Firms Share by Revenue ($ mn), from 2007 to 2008 173
Table 128: Histology and Cytology, Spain, Firms Share by Revenue ($ mn), from 2007 to 2008 174
Table 129: Immuno Chemistry, Spain, Firms Share by Revenue ($ mn), from 2007 to 2008 176
Table 130: Infectious Immunology, Spain, Firms Share by Revenue ($ mn), from 2007 to 2008 178
Table 131: Microbiology Culture, Spain, Firms Share by Revenue ($ mn), from 2007 to 2008 179
Table 132: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), from 2000 to 2015 180
Table 133: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Historic, from 2000 to 2008 182
Table 134: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Projection , from 2008 to 2015 184
Table 135: Clinical Chemistry, United Kingdom, Distribution Share by Revenue ($mn), from 2007 to 2008 185
Table 136: Genetic Testing, United Kingdom, Distribution Share by Revenue ($mn), from 2007 to 2008 185
Table 137: Haematology, United Kingdom, Distribution Share by Revenue ($mn), from 2007 to 2008 186
Table 138: Histology and Cytology, United Kingdom, Distribution Share by Revenue ($mn), from 2007 to 2008 186
Table 139: Immuno Chemistry, United Kingdom, Distribution Share by Revenue ($mn), from 2007 to 2008 187
Table 140: Infectious Immunology, United Kingdom, Distribution Share by Revenue ($mn), from 2007 to 2008 187
Table 141: Microbiology Culture, United Kingdom, Distribution Share by Revenue ($mn), from 2007 to 2008 188
Table 142: In Vitro Diagnostics, United Kingdom, Firms Share by Revenue ($ mn), from 2007 to 2008 189
Table 143: Clinical Chemistry, United Kingdom, Firms Share by Revenue ($ mn), from 2007 to 2008 190
Table 144: Genetic Testing, United Kingdom, Firms Share by Revenue ($ mn), from 2007 to 2008 191
Table 145: Haematology, United Kingdom, Firms Share by Revenue ($ mn), from 2007 to 2008 193
Table 146: Histology and Cytology, United Kingdom, Firms Share by Revenue ($ mn), from 2007 to 2008 195
Table 147: Immuno Chemistry, United Kingdom, Firms Share by Revenue ($ mn), from 2007 to 2008 197
Table 148: Infectious Immunology, United Kingdom, Firms Share by Revenue ($ mn), from 2007 to 2008 199
Table 149: Microbiology Culture, United Kingdom, Firms Share by Revenue ($ mn), from 2007 to 2008 200
Table 150: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), from 2000 to 2015 201
Table 151: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Historic, from 2000 to 2008 203
Table 152: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Projection , from 2008 to 2015 205
Table 153: Clinical Chemistry, Brazil, Distribution Share by Revenue ($mn), from 2007 to 2008 206
Table 154: Genetic Testing, Brazil, Distribution Share by Revenue ($mn), from 2007 to 2008 206
Table 155: Haematology, Brazil, Distribution Share by Revenue ($mn), from 2007 to 2008 207
Table 156: Histology And Cytology, Brazil, Distribution Share by Revenue ($mn), from 2007 to 2008 207
Table 157: Immuno Chemistry, Brazil, Distribution Share by Revenue ($mn), from 2007 to 2008 208
Table 158: Infectious Immunology, Brazil, Distribution Share by Revenue ($mn), from 2007 to 2008 208
Table 159: Microbiology Culture, Brazil, Distribution Share by Revenue ($mn), from 2007 to 2008 209
Table 160: In Vitro Diagnostics, Brazil, Firms Share by Revenue ($ mn), from 2007 to 2008 210
Table 161: Clinical Chemistry, Brazil, Firms Share by Revenue ($ mn), from 2007 to 2008 211
Table 162: Genetic Testing, Brazil, Firms Share by Revenue ($ mn), from 2007 to 2008 212
Table 163: Haematology, Brazil, Firms Share by Revenue ($ mn), from 2007 to 2008 213
Table 164: Histology And Cytology, Brazil, Firms Share by Revenue ($ mn), from 2007 to 2008 214
Table 165: Immuno Chemistry, Brazil, Firms Share by Revenue ($ mn), from 2007 to 2008 216
Table 166: Infectious Immunology, Brazil, Firms Share by Revenue ($ mn), from 2007 to 2008 218
Table 167: Microbiology Culture, Brazil, Firms Share by Revenue ($ mn), from 2007 to 2008 219
Table 168: In Vitro Diagnostics, Canada, Overall Revenue ($ mn), from 2000 to 2015 220
Table 169: In Vitro Diagnostics, Canada, Overall Revenue ($ mn), Historic, from 2000 to 2008 222
Table 170: In Vitro Diagnostics, Canada, Overall Revenue ($ mn), Projection , from 2008 to 2015 224
Table 171: Clinical Chemistry, Canada, Distribution Share by Revenue ($mn), from 2007 to 2008 225
Table 172: Genetic Testing, Canada, Distribution Share by Revenue ($mn), from 2007 to 2008 225
Table 173: Haematology, Canada, Distribution Share by Revenue ($mn), from 2007 to 2008 226
Table 174: Histology And Cytology, Canada, Distribution Share by Revenue ($mn), from 2007 to 2008 226
Table 175: Immuno Chemistry, Canada, Distribution Share by Revenue ($mn), from 2007 to 2008 227
Table 176: Infectious Immunology, Canada, Distribution Share by Revenue ($mn), from 2007 to 2008 227
Table 177: Microbiology Culture, Canada, Distribution Share by Revenue ($mn), from 2007 to 2008 228
Table 178: In Vitro Diagnostics, Canada, Firms Share by Revenue ($ mn), from 2007 to 2008 229
Table 179: Clinical Chemistry, Canada, Firms Share by Revenue ($ mn), from 2007 to 2008 230
Table 180: Genetic Testing, Canada, Firms Share by Revenue ($ mn), from 2007 to 2008 231
Table 181: Haematology, Canada, Firms Share by Revenue ($ mn), from 2007 to 2008 232
Table 182: Histology And Cytology, Canada, Firms Share by Revenue ($ mn), from 2007 to 2008 233
Table 183: Immuno Chemistry, Canada, Firms Share by Revenue ($ mn), from 2007 to 2008 235
Table 184: Infectious Immunology, Canada, Firms Share by Revenue ($ mn), from 2007 to 2008 237
Table 185: Microbiology Culture, Canada, Firms Share by Revenue ($ mn), from 2007 to 2008 238
Table 186: In Vitro Diagnostics, India, Overall Revenue ($ mn), from 2000 to 2015 239
Table 187: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, from 2000 to 2008 241
Table 188: In Vitro Diagnostics, India, Overall Revenue ($ mn), Projection , from 2008 to 2015 243
Table 189: Clinical Chemistry, India, Distribution Share by Revenue ($mn), from 2007 to 2008 244
Table 190: Genetic Testing, India, Distribution Share by Revenue ($mn), from 2007 to 2008 244
Table 191: Haematology, India, Distribution Share by Revenue ($mn), from 2007 to 2008 245
Table 192: Histology And Cytology, India, Distribution Share by Revenue ($mn), from 2007 to 2008 245
Table 193: Immuno Chemistry, India, Distribution Share by Revenue ($mn), from 2007 to 2008 246
Table 194: Infectious Immunology, India, Distribution Share by Revenue ($mn), from 2007 to 2008 246
Table 195: Microbiology Culture, India, Distribution Share by Revenue ($mn), from 2007 to 2008 247
Table 196: In Vitro Diagnostics, India, Firms Share by Revenue ($ mn), from 2007 to 2008 248
Table 197: Clinical Chemistry, India, Firms Share by Revenue ($ mn), from 2007 to 2008 250
Table 198: Genetic Testing, India, Firms Share by Revenue ($ mn), from 2007 to 2008 251
Table 199: Haematology, India, Firms Share by Revenue ($ mn), from 2007 to 2008 252
Table 200: Histology And Cytology, India, Firms Share by Revenue ($ mn), from 2007 to 2008 253
Table 201: Immuno Chemistry, India, Firms Share by Revenue ($ mn), from 2007 to 2008 255
Table 202: Infectious Immunology, India, Firms Share by Revenue ($ mn), from 2007 to 2008 257
Table 203: Microbiology Culture, India, Firms Share by Revenue ($ mn), from 2007 to 2008 259
Table 204: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), from 2000 to 2015 260
Table 205: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Historic, from 2000 to 2008 262
Table 206: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Projection , from 2008 to 2015 264
Table 207: Clinical Chemistry, Australia, Distribution Share by Revenue ($mn), from 2007 to 2008 265
Table 208: Genetic Testing, Australia, Distribution Share by Revenue ($mn), from 2007 to 2008 265
Table 209: Haematology, Australia, Distribution Share by Revenue ($mn), from 2007 to 2008 266
Table 210: Histology And Cytology, Australia, Distribution Share by Revenue ($mn), from 2007 to 2008 266
Table 211: Immuno Chemistry, Australia, Distribution Share by Revenue ($mn), from 2007 to 2008 267
Table 212: Infectious Immunology, Australia, Distribution Share by Revenue ($mn), from 2007 to 2008 267
Table 213: Microbiology Culture, Australia, Distribution Share by Revenue ($mn), from 2007 to 2008 268
Table 214: In Vitro Diagnostics, Australia, Firms Share by Revenue ($ mn), from 2007 to 2008 269
Table 215: Clinical Chemistry, Australia, Firms Share by Revenue ($ mn), from 2007 to 2008 270
Table 216: Genetic Testing, Australia, Firms Share by Revenue ($ mn), from 2007 to 2008 271
Table 217: Haematology, Australia, Firms Share by Revenue ($ mn), from 2007 to 2008 272
Table 218: Histology And Cytology, Australia, Firms Share by Revenue ($ mn), from 2007 to 2008 273
Table 219: Immuno Chemistry, Australia, Firms Share by Revenue ($ mn), from 2007 to 2008 275
Table 220: Infectious Immunology, Australia, Firms Share by Revenue ($ mn), from 2007 to 2008 277
Table 221: Microbiology Culture, Australia, Firms Share by Revenue ($ mn), from 2007 to 2008 278
Table 222: Sysmex Corporation Pipeline Products by Equipment Type 280
Table 223: Sysmex Corporation Pipeline Products By Development Stage 280
Table 224: Sysmex Corporation Pipeline Products By Therapy Area 280
Table 225: Sysmex Corporation Pipeline Products By News Summary 281
Table 226: Abbott Laboratories Pipeline Products by Equipment Type 282
Table 227: Abbott Laboratories Pipeline Products By Development Stage 282
Table 228: Abbott Laboratories Pipeline Products By Therapy Area 282
Table 229: Beckman Coulter, Inc. Pipeline Products by Equipment Type 283
Table 230: Beckman Coulter, Inc. Pipeline Products By Development Stage 284
Table 231: Beckman Coulter, Inc. Pipeline Products By Therapy Area 285
Table 232: Beckman Coulter, Inc. Pipeline Products By News Summary 285
Table 233: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 286
Table 234: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 287
Table 235: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 287
Table 236: Phadia AB Pipeline Products by Equipment Type 290
Table 237: Phadia AB Pipeline Products By Development Stage 290
Table 238: Phadia AB Pipeline Products By Therapy Area 291
Table 239: Phadia AB Pipeline Products By News Summary 291
Table 240: DiaSorin S.p.A Pipeline Products by Equipment Type 292
Table 241: DiaSorin S.p.A Pipeline Products By Development Stage 292
Table 242: DiaSorin S.p.A Pipeline Products By Therapy Area 292
Table 243: Gen-Probe Incorporated Pipeline Products by Equipment Type 294
Table 244: Gen-Probe Incorporated Pipeline Products By Development Stage 295
Table 245: Gen-Probe Incorporated Pipeline Products By Therapy Area 295
Table 246: Gen-Probe Incorporated Pipeline Products By Clinical Trials 295
Table 247: Gen-Probe Incorporated Pipeline Products By News Summary 296
Table 248: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type 297
Table 249: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage 298
Table 250: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area 298
Table 251: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials 298
Table 252: Inverness Medical Innovations, Inc. Pipeline Products By News Summary 299
Table 253: Calypte Biomedical Corporation Pipeline Products by Equipment Type 302
Table 254: Calypte Biomedical Corporation Pipeline Products By Development Stage 302
Table 255: Calypte Biomedical Corporation Pipeline Products By Therapy Area 302
Table 256: Calypte Biomedical Corporation Pipeline Products By News Summary 303
Table 257: CytoCore, Inc. Pipeline Products by Equipment Type 304
Table 258: CytoCore, Inc. Pipeline Products By Development Stage 305
Table 259: CytoCore, Inc. Pipeline Products By Therapy Area 305
Table 260: CytoCore, Inc. Pipeline Products By Clinical Trials 305
Table 261: Daxor Corporation Pipeline Products by Equipment Type 306
Table 262: Daxor Corporation Pipeline Products By Development Stage 306
Table 263: Daxor Corporation Pipeline Products By Therapy Area 307
Table 264: IRIS International, Inc. Pipeline Products by Equipment Type 308
Table 265: IRIS International, Inc. Pipeline Products By Development Stage 308
Table 266: IRIS International, Inc. Pipeline Products By Therapy Area 309
Table 267: IRIS International, Inc. Pipeline Products By News Summary 309
Table 268: Onconome, Inc. Pipeline Products by Equipment Type 310
Table 269: Onconome, Inc. Pipeline Products By Development Stage 310
Table 270: Onconome, Inc. Pipeline Products By Therapy Area 310
Table 271: Onconome, Inc. Pipeline Products By Clinical Trials 311
Table 272: Onconome, Inc. Pipeline Products By News Summary 311
Table 273: Targeted Diagnostics & Therapeutics, Inc. Pipeline Products by Equipment Type 312
Table 274: Targeted Diagnostics & Therapeutics, Inc. Pipeline Products By Development Stage 312
Table 275: Targeted Diagnostics & Therapeutics, Inc. Pipeline Products By Therapy Area 313
Table 276: Targeted Diagnostics & Therapeutics, Inc. Pipeline Products By News Summary 313
Table 277: American Bio Medica Corporation Pipeline Products by Equipment Type 315
Table 278: American Bio Medica Corporation Pipeline Products By Development Stage 315
Table 279: American Bio Medica Corporation Pipeline Products By Therapy Area 316
Table 280: American Bio Medica Corporation Pipeline Products By News Summary 316
Table 281: Laboratory Corporation of America Holdings Pipeline Products by Equipment Type 317
Table 282: Laboratory Corporation of America Holdings Pipeline Products By Development Stage 318
Table 283: Laboratory Corporation of America Holdings Pipeline Products By Therapy Area 318
Table 284: Laboratory Corporation of America Holdings Pipeline Products By News Summary 318
Table 285: American Diagnostica Inc. Pipeline Products by Equipment Type 319
Table 286: American Diagnostica Inc. Pipeline Products By Development Stage 319
Table 287: American Diagnostica Inc. Pipeline Products By Therapy Area 319
Table 288: GRANT Life Sciences, Inc. Pipeline Products by Equipment Type 320
Table 289: GRANT Life Sciences, Inc. Pipeline Products By Development Stage 320
Table 290: GRANT Life Sciences, Inc. Pipeline Products By Therapy Area 321
Table 291: GRANT Life Sciences, Inc. Pipeline Products By News Summary 321
Table 292: Luminex Corporation Pipeline Products by Equipment Type 322
Table 293: Luminex Corporation Pipeline Products By Development Stage 323
Table 294: Luminex Corporation Pipeline Products By Therapy Area 323
Table 295: Akonni Biosystems Inc Pipeline Products by Equipment Type 324
Table 296: Akonni Biosystems Inc Pipeline Products By Development Stage 324
Table 297: Akonni Biosystems Inc Pipeline Products By Therapy Area 325
Table 298: Progentech USA, Inc. Pipeline Products by Equipment Type 326
Table 299: Progentech USA, Inc. Pipeline Products By Development Stage 326
Table 300: Progentech USA, Inc. Pipeline Products By Therapy Area 326
Table 301: Source MDx Pipeline Products by Equipment Type 327
Table 302: Source MDx Pipeline Products By Development Stage 328
Table 303: Source MDx Pipeline Products By Therapy Area 329
Table 304: Source MDx Pipeline Products By Clinical Trials 329
Table 305: Eiken Chemical Co.,Ltd. Pipeline Products by Equipment Type 331
Table 306: Eiken Chemical Co.,Ltd. Pipeline Products By Development Stage 331
Table 307: Eiken Chemical Co.,Ltd. Pipeline Products By Therapy Area 331
Table 308: China Medical Technologies, Inc. Pipeline Products by Equipment Type 333
Table 309: China M
